These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31815750)

  • 1. Carbapenem use in critically ill patients.
    Patrier J; Timsit JF
    Curr Opin Infect Dis; 2020 Feb; 33(1):86-91. PubMed ID: 31815750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
    Muller A; Bertrand X; Rogues AM; Péfau M; Alfandari S; Gauzit R; Dumartin C; Gbaguidi-Haore H;
    Antimicrob Resist Infect Control; 2018; 7():11. PubMed ID: 29387345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.
    Poline J; Postaire M; Parize P; Pilmis B; Bille E; Zahar JR; Frange P; Cohen JF; Lortholary O; Toubiana J
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1039-1048. PubMed ID: 33389261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.
    Ishii J; Nishikimi M; De Bus L; De Waele J; Takaba A; Kuriyama A; Kobayashi A; Tanaka C; Hashi H; Hashimoto H; Nashiki H; Shibata M; Kanamoto M; Inoue M; Hashimoto S; Katayama S; Fujiwara S; Kameda S; Shindo S; Komuro T; Kawagishi T; Kawano Y; Fujita Y; Kida Y; Hara Y; Yoshida H; Fujitani S; Shime N;
    Microbiol Spectr; 2024 Jul; 12(7):e0034224. PubMed ID: 38864641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carbapenem consumption patterns on the molecular epidemiology and carbapenem resistance of Acinetobacter baumannii.
    Mózes J; Ebrahimi F; Gorácz O; Miszti C; Kardos G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1654-1662. PubMed ID: 25261064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of carbapenem-resistant Gram-negative infections globally.
    Brink AJ
    Curr Opin Infect Dis; 2019 Dec; 32(6):609-616. PubMed ID: 31567571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Barbier F; Bailly S; Schwebel C; Papazian L; Azoulay É; Kallel H; Siami S; Argaud L; Marcotte G; Misset B; Reignier J; Darmon M; Zahar JR; Goldgran-Toledano D; de Montmollin É; Souweine B; Mourvillier B; Timsit JF;
    Intensive Care Med; 2018 May; 44(5):616-626. PubMed ID: 29663045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.
    Datta S; Roy S; Chatterjee S; Saha A; Sen B; Pal T; Som T; Basu S
    PLoS One; 2014; 9(11):e112101. PubMed ID: 25406074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review.
    Zequinão T; Telles JP; Gasparetto J; Tuon FF
    Rev Soc Bras Med Trop; 2020; 53():e20200413. PubMed ID: 33174959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Available carbapenems: Properties and differences].
    Martínez MJ; García MI; Sánchez EG; Sánchez JE
    Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():53-64. PubMed ID: 21130931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.